General Information of the Compound
| Compound ID |
CP0167329
|
||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Compound Name |
2-phenyl-N-(pyridin-4-yl)quinazolin-4-amine
Show/Hide
|
||||||||||||||||||
| Synonyms |
2-phenyl-N-(pyridin-4-yl)quinazolin-4-amine
4-(4-Pyridvlamino)-2-Phenyl Quinazoline
4-(4-pyridylamino)-2-penyl quinazoline
4-(4-pyridylamino)-2-phenyl quinazoline
AC1O5DWY
AKOS002341780
AKOS003232028
BDBM50293513
CHEMBL564660
MCULE-2242877238
MolPort-002-121-406
QGWNGFYEPGNYNY-UHFFFAOYSA-N
SCHEMBL412953
STL388203
ZINC13633702
Show/Hide
|
||||||||||||||||||
| Structure |
|
||||||||||||||||||
| Formula |
C19H14N4
|
||||||||||||||||||
| Molecular Weight |
298.349
|
||||||||||||||||||
| Canonical SMILES |
N(c1ccncc1)c1nc(nc2ccccc12)-c1ccccc1
Show/Hide
|
||||||||||||||||||
| InChI |
InChI=1S/C19H14N4/c1-2-6-14(7-3-1)18-22-17-9-5-4-8-16(17)19(23-18)21-15-10-12-20-13-11-15/h1-13H,(H,20,21,22,23)
Show/Hide
|
||||||||||||||||||
| InChIKey |
QGWNGFYEPGNYNY-UHFFFAOYSA-N
|
||||||||||||||||||
| Physicochemical Property |
"RO5" indicates the cutoff set by lipinski's rule of five: (1) Molecular weight less than 500 Dalton; (2) xlogp less than 5; (3) No more than 5 hbonddonor (Hydrogen Bond Donor Count); (4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count); (5) No more than 10 rotbonds (Rotatable Bond Count). Show/Hide
|
||||||||||||||||||
| Click to Show/Hide the External Link(s) of This Compound | |||||||||||||||||||
| PubChem ID | |||||||||||||||||||
| ChEMBL ID | |||||||||||||||||||
Map of Molecular Bioactivity Related to the Compound
|
Map of Molecular Bioactivity Related to the Compound Compound Cell Line Protein Bioactivity Value: <= 0.1 μM > 0.1 μM and <= 10 μM > 10 μM Imprecise Activity |
|
|---|
Table of Molecular Bioactivities Related to the Compound
Clinical Information about the Compound